PIPERNO, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 26.837
AS - Asia 10.371
EU - Europa 9.115
SA - Sud America 1.524
Continente sconosciuto - Info sul continente non disponibili 786
AF - Africa 233
OC - Oceania 18
Totale 48.884
Nazione #
US - Stati Uniti d'America 25.268
SG - Singapore 3.733
CN - Cina 2.371
IT - Italia 1.812
HK - Hong Kong 1.527
CA - Canada 1.365
RU - Federazione Russa 1.318
DE - Germania 1.103
BR - Brasile 1.097
SE - Svezia 1.093
VN - Vietnam 1.087
IE - Irlanda 968
UA - Ucraina 860
GB - Regno Unito 532
FR - Francia 431
BD - Bangladesh 320
IN - India 313
FI - Finlandia 276
AT - Austria 156
AR - Argentina 143
KR - Corea 141
TR - Turchia 129
IQ - Iraq 104
NL - Olanda 97
JP - Giappone 95
PK - Pakistan 91
ID - Indonesia 88
ES - Italia 86
MX - Messico 78
ZA - Sudafrica 66
BE - Belgio 65
PL - Polonia 65
SA - Arabia Saudita 64
DK - Danimarca 63
CO - Colombia 60
EC - Ecuador 58
PH - Filippine 49
UZ - Uzbekistan 48
VE - Venezuela 48
PE - Perù 39
BG - Bulgaria 31
MA - Marocco 28
ET - Etiopia 27
CL - Cile 26
CR - Costa Rica 26
KE - Kenya 25
LT - Lituania 25
MY - Malesia 25
PY - Paraguay 22
EG - Egitto 20
CH - Svizzera 19
JM - Giamaica 19
NP - Nepal 19
TN - Tunisia 19
BO - Bolivia 17
JO - Giordania 17
RO - Romania 16
AE - Emirati Arabi Uniti 15
AU - Australia 15
IR - Iran 15
DO - Repubblica Dominicana 14
OM - Oman 13
CZ - Repubblica Ceca 12
HU - Ungheria 12
KZ - Kazakistan 12
DZ - Algeria 11
EE - Estonia 10
GR - Grecia 10
IL - Israele 10
TW - Taiwan 10
AZ - Azerbaigian 9
NI - Nicaragua 9
SV - El Salvador 9
TH - Thailandia 9
UY - Uruguay 9
GT - Guatemala 8
PS - Palestinian Territory 8
BH - Bahrain 7
HN - Honduras 7
HR - Croazia 7
KG - Kirghizistan 7
PA - Panama 7
RS - Serbia 7
SN - Senegal 7
AM - Armenia 6
EU - Europa 6
PT - Portogallo 6
BA - Bosnia-Erzegovina 5
MD - Moldavia 5
NG - Nigeria 5
NO - Norvegia 5
SC - Seychelles 5
TT - Trinidad e Tobago 5
BB - Barbados 4
GE - Georgia 4
GY - Guiana 4
LB - Libano 4
AL - Albania 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
Totale 48.030
Città #
Ann Arbor 3.013
Ashburn 2.540
Singapore 2.167
Woodbridge 1.751
Hong Kong 1.492
Fairfield 1.438
Houston 1.361
San Jose 1.222
Chandler 1.026
Toronto 1.013
Dublin 934
Jacksonville 917
Wilmington 755
Frankfurt am Main 674
Council Bluffs 604
Seattle 601
Milan 600
Dearborn 565
New York 517
Cambridge 514
Santa Clara 427
Los Angeles 391
Princeton 369
Beijing 345
Chicago 327
Dallas 308
Ho Chi Minh City 298
The Dalles 295
Hanoi 257
Nanjing 236
Shanghai 190
Hefei 185
Lauterbourg 175
Lawrence 174
Rome 163
Lachine 155
Altamura 136
Seoul 130
Vienna 129
Buffalo 127
São Paulo 118
Moscow 114
Boardman 107
San Diego 102
Orem 82
Nanchang 75
Munich 74
Helsinki 72
Phoenix 69
Andover 67
Brooklyn 66
Guangzhou 66
Shenyang 65
Montreal 61
Tokyo 60
Columbus 58
Denver 58
London 58
Brussels 54
Hebei 54
Jinan 49
Atlanta 48
Changsha 48
Dong Ket 47
Jakarta 45
Ottawa 45
Turin 45
Da Nang 43
San Francisco 43
Tianjin 43
Philadelphia 42
Rio de Janeiro 42
Warsaw 42
Tashkent 41
Jiaxing 40
Turku 40
Boston 38
Belo Horizonte 37
Chennai 36
Dhaka 36
Falls Church 36
Salt Lake City 35
Nuremberg 34
Zhengzhou 34
Tampa 33
Haiphong 32
Baghdad 31
Figino 31
Washington 29
Johannesburg 28
Lahore 28
Charlotte 27
Norwalk 25
Addis Ababa 24
Brasília 24
Mountain View 24
Stockholm 24
Fremont 23
Mexico City 23
Ningbo 23
Totale 31.419
Nome #
Reference Values of Ceruloplasmin across the Adult Age Range in a Large Italian Healthy Population 963
Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: A randomized clinical trial 748
Hepcidin regulation in a mouse model of acute hypoxia 627
Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia 471
GNPAT rs11558492 is not a major modifier of iron status: Study of Italian hemochromatosis patients and blood donors 437
Serum ferritin and liver features in a cohort of 15 patients affected by Gaucher disease 434
Idiopathic erythrocytosis: a germline disease? 425
Hif1a: A putative modifier of hemochromatosis 417
Re-evaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome 408
A severe hemojuvelin mutation leading to late onset of HFE2-hemochromatosis 403
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 388
Cardiac alterations in 36 consecutive patients with idiopathic haemochromatosis: polygraphic and echocardiographic evaluation 378
Inherited iron overload disorders 369
Hepcidin regulation in a mouse model of acute hypoxia 368
Juvenile Hemochromatosis 368
Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2 361
Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes 360
Type 3 hemochromatosis and beta-thalassemia trait 359
Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy 358
Novel mutations of the ferroportin gene (SLC40A1): Analysis of 56 consecutive patients with unexplained iron overload 356
The presence of two or more metabolic alterations and hepatic steatosis characterizes the dysmetabolic iron overload syndrome 352
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 351
Unexplained isolated hyperferritinemia without iron overload 351
Transferrin receptor 2 mutations in patients with juvenile hemochromatosis phenotype 348
Circulating factors are involved in hypoxia-induced hepcidin suppression 339
Atypical phenotype in a patient with ceruloplasmin mutations in the compound heterozygous state 338
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype 333
Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors 332
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients 331
Mental well-being in patients with transfusion-dependent anemias and hemochromatosis during the SARS-CoV-2 pandemic 329
Hereditary Hyperferritinemia 325
Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis 323
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload 321
Early impairment of large artery structure and function in Type I diabetes mellitus 319
Dysmetabolic Hepatic Iron Overload Syndrome: Analysis of Hepcidin Response to Acute Oral Iron and Chronic Iron Overload 318
Prevalence of HFE mutations in upper northern Italy: study of 1132 unrelated blood donors 315
Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome 312
Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia 312
Heterogeneity of iron overload: Clinical, biochemical, histopathologic and genetic study of 70 patients 311
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 311
Ferroportin disease: A novel SLC40A1 mutation 311
Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia? 307
Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports 304
Effects of venesections and restricted diet in patients with the Insulin-resistance hepatic iron overload syndrome 303
UNEXPLAINED ISOLATED HYPERFERRITINEMIA IN PATIENTS WITHOUT MUTATIONS IN FERRITIN GENE AND L-FERRITIN IRES REGIONS 303
Increased serum ferritin is common in men with essential hypertension 300
Hypoadiponectinemia is associated with insulin resistance in patients with non-HFE related hepatic iron overload 299
Hepatocellular carcinoma in Gaucher disease: an international case series 299
Hepcidin expression in iron overload diseases is variably modulated by circulating factors 297
Identification of novel mutations by targeted NGS panel in patients with hyperferritinemia 297
IRON AND HYPOXIA LINK: DOWNREGULATION OF LUCIFERASE ACTIVITY OF HEPCIDIN PROMOTER BY HYPOXIC SERA IN HUH-7 CELLS 295
Hyperferritinemia and diagnosis of type 1 Gaucher disease 295
Iron Overload Increases Sympathetic Nervous Activity: Study in Hemochromatosis Patients at Diagnosis and Iron Depletion 294
A time course of hepcidin response to oral iron challenge in hfe and tfr2 hemochromatosis patients 293
Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project 289
Ceruloplasmin variants might have different effects in different iron overload disorders 288
HFE and SLC40A1 polymorphisms in patients with unexplained iron overload 286
Angiotensin converting enzyme insertion/deletion polymorphism is related to pressor response to high altitude hypoxia. results of highcare project 285
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure 284
Prevalence of C282Y and E168X HFE mutations in an italian population of northern european ancestry 284
The iron-hypoxia link: hepcidin has a central role in the response to acute and chronic exposure to hypobaric hypoxia. data from the highcare project 282
Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia 281
S65C frequency in Italian patients with hemochromatosis, porphyria cutanea tarda and chronic viral hepatitis with iron overload 279
Different cortical excitability profiles in hereditary brain iron and copper accumulation 278
GNPAT rs11558492 is not associated to iron overload in Italian HFE p.C282Y homozygotes 277
Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia 273
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 273
Reduced expression of hepcidin in patients with myelodysplastic syndrome and myelofibrosis: The causes might be more heterogeneous than in thalassaemia 272
Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HEF-Hemochromatosis 269
Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract 268
Higher than expected progranulin mutaiton rate in a case series of Ialian FTLD patients 267
Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders 267
Effects of hypobaric hypoxia at high altitude on humoral regulation of blood pressure and body fluids. results of highcare project 266
Analysis of Polymorphisms of Genes Regulating Hepcidin Transcription in Hfe-Hemochromatosis 266
Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype 266
Clinical and Molecular features of the patients with Idiopathic Erythrocytosis 266
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 264
Commentary 264
The iron status of Italian subjects with beta-thalassemia trait 257
HLA typing in 67 Italian patients with idiopathic hemochromatosis and their relatives 256
Haemochromatosis in patients with β-thalassaemia trait 255
Biochemical and genetic defects underlying human congenital hypotransferrinemia 255
Revisitation of a cohort of 482 Italian patients with hereditary hemochromatosis: Changes in the last three decades 255
Spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis 252
Immunohistochemical evaluation of a panel of monoclonal antibodies for the diagnosis of small cell lung cancer 252
Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: Its relationship to hepatic fibrosis, activity of the disease and iron overload 250
Myelodysplastic Syndromes and Iron Chelation Therapy 250
Homozygous deletion of HFE: The Sardinian hemochromatosis? 249
Transferrin Saturation and Serum Ferritin Are Main Predictors of Liver Iron Content in Subjects With Hyperferritinemia 248
The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis 248
Oxidative stress and antioxidant defence mechanisms in response to chronic hypobaric hypoxia. Results of the HIGHCARE project 248
Single breath-hold multiecho mri sequences (at 1.5t) for the simultaneous lipid quantification and t2*measurement in patients with increased serum ferritin levels 247
Natural history of juvenile haemochromatosis 245
Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica) study group 243
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis 243
Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation 239
Erythrocyte ferritin in thalassemia syndromes 237
Long-Term Survival and Risk of Hepatocellular Carcinoma Occurrence in Italian Patients with Hereditary Hemochromatosis 236
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension 235
Immunohistochemical evidence for a lack of ferritin in duodenal absorptive epithelial cells in idiopathic hemochromatosis 234
Totale 31.794
Categoria #
all - tutte 154.096
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 154.096


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.748 0 0 0 231 181 135 115 137 110 160 196 483
2022/20233.871 552 1.107 344 344 226 583 26 233 250 22 115 69
2023/20242.611 100 95 97 71 341 614 565 162 193 48 53 272
2024/20255.730 396 675 231 241 565 176 225 288 740 815 496 882
2025/202614.934 1.331 757 1.018 1.460 1.782 795 2.094 665 1.207 1.265 1.425 1.135
2026/20274.805 1.041 851 1.531 1.382 0 0 0 0 0 0 0 0
Totale 48.884